CDKN2A and Miyoshi myopathy: Yin et al. described how high expression levels of ANRIL (antisense non-coding RNA in the INK4-ARF locus), combined with the downregulation of miR-34a, miR-125a or miR-186, were associated with worse PFS and OS in MM patients [33].